The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a
wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu …

Abstract Purpose of Review The purpose of the study was to examine the published
evidence on the cardiovascular risk related to the use of cannabis-based products by …

Background and objective Marijuana use has gained popularity following legalization in the
US. Marijuana can affect the heart through various mechanisms. This study aims to conduct …

Synthetic cannabinoids (SC), are a novel class of designer drugs which emerged as a drug
of abuse in the late 2000's. We report a case series of 6 patients who may have smoked a …

Background: Whilst illegal drug use has, largely, been declining in the UK over the past
decade, this period has witnessed the emergence of a range of novel psychoactive …

As per the Centers for Disease Control and Prevention (CDC), the incidence of myocardial
infarction (MI) is reported to be 805,000 cases annually in the United States (US). Although …

Abstract Introduction Synthetic Cannabinoid Receptor Agonists (SCRA) were legally
available in New Zealand (NZ) prior to May 2014. During the period November 2012 …

Utilization of marijuana as a medicinal agent is becoming increasingly popular, and so far,
25 states have legalized it for medical purposes. However, there is emerging evidence that …

Novel drugs of abuse are synthetic illicit drugs, or analogues of known illicit drugs, that can
be more potent. Novel drugs of abuse are often labeled as designer drugs, research …

In the recent decade, numerous new psychoactive substances (NPSs) have been added to
the illicit drug market. These are synthetized to mimic the effects of classic drugs of abuse …